Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences Inks CJD Collaboration with Medical Research Council

NEW YORK, Nov. 24 (GenomeWeb News) - Proteome Sciences said today that it has signed a deal to work with the Medical Research Council to identify differential protein expression in patients with Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.


According to Proteome Sciences, using samples from age and sex matched patients with the diseases, it will undertake protein seperation, indentification, and characterization to search for biomarkers for new diagnostics, prognostics, and therapeutics.


Specific terms of the partnership were not disclosed.



The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.